Effective anti-programmed death-1 therapy in a SUFU-mutated patient with Gorlin-Goltz syndrome. [electronic resource]
Producer: 20191125Description: 747-749 p. digitalISSN:- 1365-2133
- Aged
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Basal Cell Nevus Syndrome -- drug therapy
- Humans
- Infusions, Intravenous
- Male
- Mutation
- Off-Label Use
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Repressor Proteins -- genetics
- Skin Neoplasms -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.